Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7

被引:243
作者
Zoppi, Vittoria [1 ,2 ]
Hughes, Scott J. [1 ]
Maniaci, Chiara [1 ,3 ,6 ]
Testa, Andrea [1 ]
Gmaschitz, Teresa [4 ]
Wieshofer, Corinna [4 ]
Koegl, Manfred [4 ]
Riching, Kristin M. [5 ]
Daniels, Danette L. [5 ]
Spallarossa, Andrea [2 ]
Ciulli, Alessio [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dow St, Dundee DD1 5EH, Scotland
[2] Univ Genoa, Dipartimento Farm, Sez Chim Farmaco & Prod Cosmet, Viale Benedetto XV 3, I-16132 Genoa, Italy
[3] Univ Dundee, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Sch Life Sci,James Black Ctr, Dow St, Dundee DD1 5EH, Scotland
[4] Boehringer Ingelheim RCV GmbH & Co KG, A-1221 Vienna, Austria
[5] Promega Corp, 2800 Woods Hollow Rd, Madison, WI 53711 USA
[6] Univ Oxford, Dept Chem, Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England
基金
英国惠康基金; 欧洲研究理事会;
关键词
E3 UBIQUITIN LIGASE; INDUCED PROTEIN-DEGRADATION; STRUCTURE-GUIDED DESIGN; TUMOR-SUPPRESSOR GENE; SWI/SNF COMPLEXES; DISCOVERY; BROMODOMAIN; RECOGNITION; SUBUNIT; ALPHA;
D O I
10.1021/acs.jmedchem.8b01413
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Developing PROTACs to redirect the ubiquitination activity of E3 ligases and potently degrade a target protein within cells can be a lengthy and unpredictable process, and it remains unclear whether any combination of E3 and target might be productive for degradation. We describe a probe-quality degrader for a ligase-target pair deemed unsuitable: the von Hippel-Lindau (VHL) and BRD9, a bromodomain-containing subunit of the SWI/SNF chromatin remodeling complex BAF. VHL-based degraders could be optimized from suboptimal compounds in two rounds by systematically varying conjugation patterns and linkers and monitoring cellular degradation activities, kinetic profiles, and ubiquitination, as well as ternary complex formation thermodynamics. The emerged structure-activity relationships guided the discovery of VZ185, a potent, fast, and selective degrader of BRD9 and of its close homolog BRD7. Our findings qualify a new chemical tool for BRD7/9 knockdown and provide a roadmap for PROTAC development against seemingly incompatible target-ligase combinations.
引用
收藏
页码:699 / 726
页数:28
相关论文
共 86 条
[1]   Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach [J].
Bassi, Zuni I. ;
Fillmore, Martin C. ;
Miah, Afjal H. ;
Chapman, Trevor D. ;
Maller, Claire ;
Roberts, Emma J. ;
Davis, Lauren C. ;
Lewis, Darcy E. ;
Galwey, Nicholas W. ;
Waddington, Kirsty E. ;
Parravicini, Valentino ;
Macmillan-Jones, Abigail L. ;
Gongora, Celine ;
Humphreys, Philip G. ;
Churcher, Ian ;
Prinjha, Rab K. ;
Tough, David F. .
ACS CHEMICAL BIOLOGY, 2018, 13 (10) :2862-2867
[2]   Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead [J].
Bondeson, Daniel P. ;
Smith, Blake E. ;
Burslem, George M. ;
Buhimschi, Alexandru D. ;
Hines, John ;
Jaime-Figueroa, Saul ;
Wang, Jing ;
Hamman, Brian D. ;
Ishchenko, Alexey ;
Crews, Craig M. .
CELL CHEMICAL BIOLOGY, 2018, 25 (01) :78-+
[3]  
Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]
[4]   HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins [J].
Buckley, Dennis L. ;
Raina, Kanak ;
Darricarrere, Nicole ;
Hines, John ;
Gustafson, Jeffrey L. ;
Smith, Ian E. ;
Miah, Aija H. ;
Harling, John D. ;
Crews, Craig M. .
ACS CHEMICAL BIOLOGY, 2015, 10 (08) :1831-1837
[5]   Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation [J].
Bulatov, Emil ;
Ciulli, Alessio .
BIOCHEMICAL JOURNAL, 2015, 467 :365-386
[6]   Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds [J].
Chan, Kwok-Ho ;
Zengerle, Michael ;
Testa, Andrea ;
Ciulli, Alessio .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) :504-513
[7]   MolProbity: all-atom structure validation for macromolecular crystallography [J].
Chen, Vincent B. ;
Arendall, W. Bryan, III ;
Headd, Jeffrey J. ;
Keedy, Daniel A. ;
Immormino, Robert M. ;
Kapral, Gary J. ;
Murray, Laura W. ;
Richardson, Jane S. ;
Richardson, David C. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :12-21
[8]   BRD7, a Tumor Suppressor, Interacts with p85α and Regulates PI3K Activity [J].
Chiu, Yu-Hsin ;
Lee, Jennifer Y. ;
Cantley, Lewis C. .
MOLECULAR CELL, 2014, 54 (01) :193-202
[9]   LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor [J].
Clark, Peter G. K. ;
Vieira, Lucas C. C. ;
Tallant, Cynthia ;
Fedorov, Oleg ;
Singleton, Dean C. ;
Rogers, Catherine M. ;
Monteiro, Octovia P. ;
Bennett, James M. ;
Baronio, Roberta ;
Mueller, Susanne ;
Daniels, Danette L. ;
Mendez, Jacqui ;
Knapp, Stefan ;
Brennan, Paul E. ;
Dixon, Darren J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (21) :6217-6221
[10]   Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway [J].
Collins, Ian ;
Wang, Hannah ;
Caldwell, John J. ;
Chopra, Raj .
BIOCHEMICAL JOURNAL, 2017, 474 (07) :1127-1147